Skip to main content
. 2017 Sep 1;10(9):1117–1128. doi: 10.1242/dmm.029801

Fig. 2.

Fig. 2.

Lesion areas at 6 weeks after spinal cord injury in mice treated with trimebutine or honokiol. (A) Representative images of H&E-stained longitudinal sections at 6 weeks after SCI in vehicle control (VC), trimebutine (TMB) or honokiol (HNK) groups. (B) Quantitative analysis of lesion area at 6 weeks after SCI in vehicle control, trimebutine or honokiol groups. **P<0.01 versus the vehicle control; one-way ANOVA with Tukey's post hoc test; n=3 mice/group.